Skip to main content
SpringerLink
Log in

Significance of antimitochondrial antibody profiles in primary biliary cirrhosis

  • Chapter
Primary Biliary Cirrhosis

Abstract

As is now well established, PBC can manifest itself as a benign or a progressive disease1–3. Several investigators tried to evaluate various clinical and biochemical criteria in order to distinguish these two forms and to predict the clinical outcome; several prognostic models have been established4–6. However, although these parameters do seem to allow the determination of the appropriate time for liver transplantation, they are not suitable for differentiating between patients with a benign and those with a progressive course during the early stages of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1–7.

    Article  PubMed  CAS  Google Scholar 

  2. Beswick DR, Klatskin G, Boyer JL. Asymptomatic primary biliary cirrhosis. A progress report on long-term follow up and natural history. Gastroenterology 1985;89:267–71.

    PubMed  CAS  Google Scholar 

  3. Klein R, Klöppel G, Garbe W, Fintelmann V, Berg PA. Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease: A retrospective analysis of 76 patients over 6–18 years. J Hepatol 1991;12:21–7.

    Article  PubMed  CAS  Google Scholar 

  4. Dickson ER, Grambsch PM, Fleming TR, et al.Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989;10:1–7.

    Article  PubMed  CAS  Google Scholar 

  5. Wiesner RH, Porayko MK, Dickson ER, et al.Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992;16:1290–9.

    Article  PubMed  CAS  Google Scholar 

  6. Reichen J, Widmer T, Cutting J. Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo Model. Hepatology 1991;14:504–10.

    Article  PubMed  CAS  Google Scholar 

  7. Berg PA, Klein R. Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited. Liver 1995;15:281–92.

    PubMed  CAS  Google Scholar 

  8. Klein R, Huizenga JR, Gips CH, Berg PA. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titers of AMA-subtypes after transplantation. J Hepatol 1994;20:181–9.

    Article  PubMed  CAS  Google Scholar 

  9. Klein R, Berg PA. Prognostische Bedeutung der antimitochondrialen Antikörperprofile A-D bei Patienten mit primär-biliärer Zirrhose. Dtsch Med Wschr 1988;113;1549–53.

    Article  PubMed  CAS  Google Scholar 

  10. Klein R, Pointner H, Zilly W, et al.Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver 1997;17:119–28.

    PubMed  CAS  Google Scholar 

  11. Sayers T, Leoutsakos A, Berg PA, Baum H. Antimitochondrial antibodies (AMA) in primary biliary cirrhosis. I. Separation of the PBC antigen activity from mitochondrial ATPase activity. J Bioenerg Biomembr 1981;13:255–67.

    Article  PubMed  CAS  Google Scholar 

  12. Berg PA, Klein R, Lindenborn-Fotinos J, Klöppel G. ATPase associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet 1982;2:1423–6.

    Article  PubMed  CAS  Google Scholar 

  13. Lindenborn-Fotinos J, Baum H, Berg PA. Mitochondria) antibodies in primary biliary cirrhosis. Further characterization of the M2-antigen by immunoblotting, revealing species and non-species specific determinants. Hepatology 1985;5:763–9.

    Article  PubMed  CAS  Google Scholar 

  14. Yeaman SJ, Danner DJ, Mutimer DJ, Fussey SPM, James OFW, Bassendine MF. Primary biliary cirrhosis: identification of two major M2 mitochondria) autoantigens. Lancet 1988;1:1067–70.

    Article  PubMed  CAS  Google Scholar 

  15. van de Water J, Surh CD, Leung PSC, et al.Molecular definitions, autoepitopes, and enzymatic activities of the mitochondria) autoantigens of primary biliary cirrhosis. Semin Liver Dis 1989;9:132–7.

    Article  PubMed  Google Scholar 

  16. Bassendine MF, Yeaman SJ. Serological markers of primary biliary cirrhosis: diagnosis, prognosis and subsets. Hepatology 1992;15:545–7.

    Article  PubMed  CAS  Google Scholar 

  17. Klein R, Berg PA. Anti-M4 antibodies in primary biliary cirrhosis react with sulfite oxidase, an enzyme of the mitochondrial intermembrane space. Clin Exp Immunol 1991;84:445–8.

    PubMed  CAS  Google Scholar 

  18. Davis PA, Leung P, Manns M, et al.M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena. Hepatology 1992;16:1128–36.

    Article  PubMed  CAS  Google Scholar 

  19. Palmer JM, Nieman SJ, Bassendine MF, James OFW. M4 and M9 autoantibodies in primary biliary cirrhosis–a negative study. J Hepatol 1993;18:251–4.

    Article  PubMed  CAS  Google Scholar 

  20. Bunn CC, McMorrow M. Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies. Clin Exp Immunol 1995;102:131–6.

    Article  PubMed  CAS  Google Scholar 

  21. Klein R, Berg PA. Characterization of a new mitochondria) antigen/antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis. Clin Exp Immunol 1988;74:68–74.

    PubMed  CAS  Google Scholar 

  22. Klein R, Berg PA. Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase. Clin Exp Immunol 1990;81:65–71.

    Article  PubMed  CAS  Google Scholar 

  23. Klein R, Klöppel G, Fischer R, Fintelmann V, Mating D, Berg PA. The mitochondria) antibody anti-M9–a marker for the diagnosis of early primary biliary cirrhosis (PBC). J Hepatol 1988;6:299–306.

    Article  PubMed  CAS  Google Scholar 

  24. Mahl TC, Shockcor W, Boyer L. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol 1994;20:707–13.

    Article  PubMed  CAS  Google Scholar 

  25. Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scand J Gastroenterol 1989;24:57–64.

    Article  PubMed  CAS  Google Scholar 

  26. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884–90.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. A. Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Keith D. Lindor (Professor of Medicine) (Professor of Medicine)

  2. The Toronto Hospital, Western Division, University of Toronto, 399 Bathurst Street, Wing 4-828, Toronto, ONT, M5T 2S8, Canada

    E. Jenny Heathcote (Professor of Medicine) (Professor of Medicine)

  3. Service d’Hepatologie et Gastroenterologie, AP — Hôpital Saint-Antoine, 184, rue Du Faubourg, Saint-Antoine, 75571, Paris, France

    Raoul Poupon (Professor of Medicine) (Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Klein, R., Berg, P.A. (1998). Significance of antimitochondrial antibody profiles in primary biliary cirrhosis. In: Lindor, K.D., Heathcote, E.J., Poupon, R. (eds) Primary Biliary Cirrhosis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4884-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4884-9_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6047-9

  • Online ISBN: 978-94-011-4884-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation